- Home
- » Tags
- » Thrombopoietin
Top View
- Stable Liver Function During Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease
- Thrombopoietin Receptor Agonists for the Treatment of Inherited
- Fine-Tuning of Hematopoietic Stem Cell Homeostasis: Novel Role for Ubiquitin Ligase
- Human Thrombopoietin Quantikine
- Cytokine Receptors and Hematopoietic Differentiation
- A Phase I Clinical, Pharmacologic, and Biologic Study Of
- Permissive Role of Thrombopoietin and Granulocyte Colony-Stimulating Factor Receptors in Hematopoietic Cell Fate Decisions in Vivo
- Immunoassay Platforms and Products: R&D Systems
- Supplementary Data
- Supplemental Methods
- DOPTELET Is a Thrombopoietin (TPO) Receptor Agonist…
- Antitumoral Activity of Allosteric Inhibitors of Protein Kinase CK2
- Targeting the FMS-Like Tyrosine Kinase 3 in Acute Myeloid Leukemia
- The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
- Thrombopoietin, Human (T1568)
- Thrombopoietin Protects Hematopoietic Stem Cells from Retrotransposon-Mediated Damage by Promoting an Antiviral Response
- Impact of MLL5 Expression on Decitabine Efficacy and DNA Methylation in Acute Myeloid Leukemia
- Cell-Penetrating TAT-FOXO3 Fusion Proteins Induce Apoptotic Cell Death in Leukemic Cells
- Tuning TPO-R Signaling to Influence Hematopoietic Stem Cell Differentiation And
- Fully Human Agonist Antibodies to Trkb Using Autocrine Cell-Based Selection from a Combinatorial Antibody Library
- The Role of Kit and Thrombopoietin in Regulation of Hematopoietic Stem Cells
- Cell Polarity in Hematopoietic Stem Cell Quiescence, Signaling and Fate Determination
- Program Slides
- Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
- Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin to Promote T Cell Migration
- JAK2V617F-Positive Myeloproliferative Neoplasms
- Regulation of Thrombopoietin Receptor Expression and Function
- Thrombopoietin Rescues in Vitro Erythroid Colony Formation from Mouse Embryos Lacking the Erythropoietin Receptor MARK W
- Thrombopoietin a Preclinical Evaluation
- The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
- An Anatomic Gene Expression Atlas of the Mouse Brain
- Use of Thrombopoietin in Combination with Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Progenitor Cell Mobilization
- Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
- Mpl Baltimore: a Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis
- Technical Report Optimization of Culture Conditions to Enhance Transfection of Human CD34؉ Cells by Electroporation
- Study of the Thrombopoietin Receptor in Essential Thrombocythemia JJ Kiladjian1,2, N Elkassar1, G Hetet1,3, J Briere1,2, B Grandchamp1 and C Gardin1,2
- ©Ferrata Storti Foundation
- Serum Thrombopoietin Levels in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
- Whole Genome Expression Profiling and Screening for Differentially
- The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human
- Spotlight Review
- Two Patterns of Thrombopoietin Signaling Suggest No Coupling Between Platelet Production and Thrombopoietin Reactivity in Thrombocytopenia-Absent Radii Syndrome
- Tuning MPL Signaling to Influence Hematopoietic Stem Cell Differentiation and Inhibit Essential Thrombocythemia Progenitors
- Eltrombopag, a Second-Generation Thrombopoietin Receptor Agonist, for Chronic Lymphocytic Leukemia-Associated ITP
- Therapeutic Potential of Janus-Activated Kinase-2 Inhibitors for the Management of Myelofibrosis
- Research Article Danggui Sini Decoction Protected Islet Endothelial Cell Survival from Hypoxic Damage Via PI3K/Akt/Enos Pathway
- FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia
- The Eltrombopag Antitumor Effect on Hepatocellular Carcinoma